Cargando…

A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer

Basal-like breast cancer (BLBC) is highly aggressive, and often characterized by BRCA1 and p53 deficiency. Although conventional mouse models enabled the investigation of BLBC at malignant stages, its initiation and pre-malignant progression remain understudied. Here, we leveraged a mouse genetic sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jianhao, Singh, Shambhavi, Zhou, Xian, Jiang, Ying, Casarez, Eli, Atkins, Kristen A., Janes, Kevin A., Zong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668031/
https://www.ncbi.nlm.nih.gov/pubmed/37815460
http://dx.doi.org/10.1242/dmm.050219
_version_ 1785149074116182016
author Zeng, Jianhao
Singh, Shambhavi
Zhou, Xian
Jiang, Ying
Casarez, Eli
Atkins, Kristen A.
Janes, Kevin A.
Zong, Hui
author_facet Zeng, Jianhao
Singh, Shambhavi
Zhou, Xian
Jiang, Ying
Casarez, Eli
Atkins, Kristen A.
Janes, Kevin A.
Zong, Hui
author_sort Zeng, Jianhao
collection PubMed
description Basal-like breast cancer (BLBC) is highly aggressive, and often characterized by BRCA1 and p53 deficiency. Although conventional mouse models enabled the investigation of BLBC at malignant stages, its initiation and pre-malignant progression remain understudied. Here, we leveraged a mouse genetic system known as mosaic analysis with double markers (MADM) to study BLBC initiation by generating rare GFP(+) Brca1, p53-deficient mammary cells alongside RFP(+) wild-type sibling cells. After confirming the close resemblance of mammary tumors arising in this model to human BLBC at both transcriptomic and genomic levels, we focused our studies on the pre-malignant progression of BLBC. Initiated GFP(+) mutant cells showed a stepwise pre-malignant progression trajectory from focal expansion to hyper-alveolarization and then to micro-invasion. Furthermore, despite morphological similarities to alveoli, hyper-alveolarized structures actually originate from ductal cells based on twin-spot analysis of GFP-RFP sibling cells. Finally, luminal-to-basal transition occurred exclusively in cells that have progressed to micro-invasive lesions. Our MADM model provides excellent spatiotemporal resolution to illuminate the pre-malignant progression of BLBC, and should enable future studies on early detection and prevention for this cancer.
format Online
Article
Text
id pubmed-10668031
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-106680312023-11-13 A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer Zeng, Jianhao Singh, Shambhavi Zhou, Xian Jiang, Ying Casarez, Eli Atkins, Kristen A. Janes, Kevin A. Zong, Hui Dis Model Mech Research Article Basal-like breast cancer (BLBC) is highly aggressive, and often characterized by BRCA1 and p53 deficiency. Although conventional mouse models enabled the investigation of BLBC at malignant stages, its initiation and pre-malignant progression remain understudied. Here, we leveraged a mouse genetic system known as mosaic analysis with double markers (MADM) to study BLBC initiation by generating rare GFP(+) Brca1, p53-deficient mammary cells alongside RFP(+) wild-type sibling cells. After confirming the close resemblance of mammary tumors arising in this model to human BLBC at both transcriptomic and genomic levels, we focused our studies on the pre-malignant progression of BLBC. Initiated GFP(+) mutant cells showed a stepwise pre-malignant progression trajectory from focal expansion to hyper-alveolarization and then to micro-invasion. Furthermore, despite morphological similarities to alveoli, hyper-alveolarized structures actually originate from ductal cells based on twin-spot analysis of GFP-RFP sibling cells. Finally, luminal-to-basal transition occurred exclusively in cells that have progressed to micro-invasive lesions. Our MADM model provides excellent spatiotemporal resolution to illuminate the pre-malignant progression of BLBC, and should enable future studies on early detection and prevention for this cancer. The Company of Biologists Ltd 2023-11-13 /pmc/articles/PMC10668031/ /pubmed/37815460 http://dx.doi.org/10.1242/dmm.050219 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Research Article
Zeng, Jianhao
Singh, Shambhavi
Zhou, Xian
Jiang, Ying
Casarez, Eli
Atkins, Kristen A.
Janes, Kevin A.
Zong, Hui
A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
title A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
title_full A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
title_fullStr A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
title_full_unstemmed A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
title_short A genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
title_sort genetic mosaic mouse model illuminates the pre-malignant progression of basal-like breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668031/
https://www.ncbi.nlm.nih.gov/pubmed/37815460
http://dx.doi.org/10.1242/dmm.050219
work_keys_str_mv AT zengjianhao ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT singhshambhavi ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT zhouxian ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT jiangying ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT casarezeli ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT atkinskristena ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT janeskevina ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT zonghui ageneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT zengjianhao geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT singhshambhavi geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT zhouxian geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT jiangying geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT casarezeli geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT atkinskristena geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT janeskevina geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer
AT zonghui geneticmosaicmousemodelilluminatesthepremalignantprogressionofbasallikebreastcancer